• Fast Track Initiative portfolio company CellFiber simultaneously launched commercial sales of two Zeito cell encapsulation systems in Japan and the United States.
• The Zeito Plus and Zeito Lite support cell manufacturing for companies and research institutions developing cell therapies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fast Track Initiative Inc published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.